Showing results (911-920 of 5,009) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|February 6, 2009
Multicenter randomized open-label phase III study comparing efficacy, safety, and tolerability of conventional carboplatin plus etoposide versus dose-intensified carboplatin plus etoposide plus lenograstim in small-cell lung cancer in "extensive disease" stageDavid Felix Heigener, Christian Manegold, Elke Jäger, et al.
American Journal of Clinical Oncology|February 6, 2009
Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapyAysen Ozturk, Sureyya Sarihan, Ilker Ercan, et al.
American Journal of Clinical Oncology|April 7, 2009
Patient selection for phase II trialsGuru Sonpavde, Matthew D Galsky, Thomas E Hutson, et al.
American Journal of Clinical Oncology|April 8, 2009
Computed tomography assessment of lung density in patients with lung cancer treated with accelerated hypofractionated radio-chemotherapy supported with amifostineMichael I Koukourakis, Pelagia G Tsoutsou, Ioannis Abatzoglou
American Journal of Clinical Oncology|February 1, 1985
New prognostic factors in squamous cell carcinoma of cervix uteriA Jakobsen, P Bichel, M Vaeth
American Journal of Clinical Oncology|February 1, 1985
Adjuvant chemotherapy of malignant melanoma. A pilot studyJ Hansson, U Ringborg, B Lagerlöf, et al.
American Journal of Clinical Oncology|November 1, 2022
Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas CancerMeriem Mokhtech, Joseph A Miccio, Kimberly Johung, et al.
American Journal of Clinical Oncology|November 3, 2022
Impact of Low-dose Chest CT Screening on the Association Between Rurality and Lung Cancer OutcomesMadeleine Hinojos, Xuan Li, Sarah Mikesell, et al.
American Journal of Clinical Oncology|August 1, 1987
Combined mitoxantrone plus doxorubicin in the treatment of breast cancerD J Stewart, D J Perrault, J A Maroun, et al.
American Journal of Clinical Oncology|September 14, 2022
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent ImmunotherapyDalia Kaakour, Garo Hagopian, Sonia Lee, et al.
Pageof 501